Glycobiology Market Is Roaring Worldwide From 2021
Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.
The
global Glycomics/Glycobiology Market is expected to grow at a CAGR of 14.4% in
the forthcoming period. Glycomics is a wide and emerging scientific field
emphasizing on defining functional aspects of glycans in biological systems.
The higher the complexity of glycome, which is defined as the range of glycans
particularly in a cell or organism leads to multiple challenges that could be
subjectively decoded.
The
challenges are resolved with progress in mass spectrometry along with expansion
of genetic and cell biology studies. On the contrary, determining a specific
glycan and glycan-binding proteins by incorporating new technology of glycan
microarrays guide the glycan function.
Request Sample Copy
of This Market Research @
https://www.millioninsights.com/industry-reports/glycomics-glycobiology-market/request-sample
Glycomics/glycobiology
industry is driven by factors such as growing investments for R&D with a
strong emphasis of pharmaceutical and biotechnology companies on innovative
product development. Rise in development of new vaccines for genetic diseases
comprising diabetes and influenza will add to the market growth in the forecast
period. Rise in government funding for R&D activities and novel approach
for drug production process are the other factors driving the market.
Product
segmentation for glycomics market includes enzymes, reagents, kits and
instruments. Enzymes are further quad furcated into glycosyltransferases,
neuraminidases, sialyl transferases and glycosidases. Enzyme segment accounts
for a high market share due to wide applications for various drug recovery
procedures. Application segment for glycomics/glycobiology industry includes
drug discovery &development diagnostics.
Regional
segmentation for glycomics/glycobiology market includes North America, Latin America,
Europe, Asia-Pacific, Middle East and Africa. North America dominates the
market due to high revenue share and presence of large pharmaceutical &
biotechnology firms. Presence of developed healthcare infrastructure and
availability of advanced products in these regions is likely to promote the
market growth.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/glycomics-glycobiology-market
Asia-Pacific’s
glycobiology industry is estimated to grow at a higher CAGR in the forecast
period due to booming healthcare infrastructure in emerging economies.
Availability of large pool of patients and low cost of clinical trials and
accessibility of skilled personnel have propelled the market growth in
Asia-Pacific’s market. The key players in the glycomics/glycobiology market
include Thermo Fisher Scientific Inc, Agilent Technologies, Bruker, Merck KGaA,
Shimazdu Corp, New England Biolabs, Waters Corporation, and Takara Bio Inc.
Market
Segment:
Glycomics/Glycobiology
Product Outlook (Revenue, USD Million, 2014 - 2025)
• Instruments
• Mass Spectrometers
• HPLC
• MALDI-TOF
• Array Systems
• Others
• Reagents
• Glycoproteins
• Monosaccharides
• Oligosaccharides
• Others
• Kits
• Glycan Labeling Kits
• Glycan Purification Kits
• Glycan Release Kits
• Others
• Enzymes
• Glycosidases
• Glycosyltransferases
• Neuraminidases
• Sialyltransferases
• Others
Glycomics/Glycobiology
Application Outlook (Revenue, USD Million, 2014 - 2025)
• Drug Discovery & Development
• Diagnostics
• Others
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• CROs
Comments
Post a Comment